11th Conference on Retroviruses and Opportunistic Infections San Francisco, California - February 8 - 11, 2004

Conf Retrovir Opportunistic Infect 2004 Feb 8-11;11:abstract no. 4

Alex Coutinho¹, P Mugyenyi², and P Solberg^3
1The AIDS Support Org, Kampala, Uganda; ²Joint Clin Res Ctr, Kampala, Uganda; and ³CDC, Kampala, Uganda

BACKGROUND: In Uganda, use of ARV began to be scaled up in the Joint Clinical Research Center providing ARV to Ugandans who could afford the price as well as some patients who were part of research cohorts. To date, of the 100,000 who require treatment, an estimated 12,000 Ugandans are on ART; and another 1,000,000 Ugandans infected in the last year.

RESULTS: Two research trials based in TASO centers are aiming to carry out operational research on 2000 TASO clients to see if it is possible to deliver ART to poor, rural-based, infected Ugandans. This will form the basis of a general scale up of ART in TASO.

CONCLUSIONS: There are particular challenges in scaling up ARV use in a resource-challenged setting, and this presentation explores those challenges while highlighting the successes of current efforts. The presentation will also discuss the role of the partnership between government, NGO, and the private sector in this scale up.

040208
4

Copyright © 2004 - Foundation for Retrovirology and Human Health. Reproduction of this abstract (other than one copy for personal reference) must be cleared through the Foundation for Retrovirology and Human Health. Licensed (AIDSLINE) from National Library of Medicine.